p.97 抽出テキスト
699. Ohsawa M, Tanno K, Itai K, et al. Comparison of predictability of future cardiovascular events between chronic kidney disease (CKD) stage based on CKD epidemiology collaboration equation and that based on modification of diet in renal disease equation in the Japanese general population―Iwate KENCO Study. Circ J 2013; 77: 1315-1325. PMID: 23428718 700. Horio M, Imai E, Yasuda Y, et al. Collaborators Developing the Japanese Equation for Estimated GFR. GFR estimation using standardized serum cystatin C in Japan. Am J Kidney Dis 2013; 61: 197-203. PMID: 22892396 701. Keith DS, Nichols GA, Gullion CM, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659- 663. PMID: 15037495 702. Ninomiya T, Kiyohara Y, Kubo M, et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: The Hisayama Study. Kidney Int 2005; 68: 228-236. PMID: 15954912 703. Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-2081. PMID: 20483451 704. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3: 1-150. https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_ CKD_GL.pdf 705. Levey AS, Grams ME, Inker LA. Uses of GFR and Albuminuria Level in Acute and Chronic Kidney Disease. N Engl J Med 2022; 386: 2120-2128. PMID: 35648704 706. Nakayama M, Sato T, Miyazaki M, et al. Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study. Hypertens Res 2011; 34: 1106-1110. PMID: 21796127 707. Yamamoto T, Nakayama M, Miyazaki M, et al. Relationship between low blood pressure and renal/cardiovascular outcomes in Japanese patients with chronic kidney disease under nephrologist care: the Gonryo study. Clin Exp Nephrol 2015; 19: 878-886. PMID: 25648765 708. Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al. DAPA-CKD Trial Committees and Investigators. Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med 2020; 383: 1436-1446. PMID: 32970396 709. Chertow GM, Vart P, Jongs N, et al. DAPA-CKD Trial Committees and Investigators. Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease. J Am Soc Nephrol 2021; 32: 2352-2361. PMID: 34272327 710. 日本糖尿病学会.糖尿病治療におけるSGLT2阻害薬の適正使用に関するRecommendation(2022年7月26日改訂).http://www.fa. kyorin.co.jp/jds/uploads/recommendation_SGLT2.pdf 711. Pitt B, Filippatos G, Agarwal R, et al. FIGARO-DKD Investigators. Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes. N Engl J Med 2021; 385: 2252-2263. PMID: 34449181 712. Bakris GL, Agarwal R, Anker SD, et al. FIDELIO-DKD Investigators. Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med 2020; 383: 2219-2229. PMID: 33264825 713. Agarwal R, Filippatos G, Pitt B, et al. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. Eur Heart J 2022; 43: 474-484. PMID: 35023547 714. Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998; 338: 1650-1656. PMID: 9614255 715. 原光彦.小児肥満症診療ガイドライン策定と肥満症対策.肥満研究 2020; 26: 328-332. 716. Barker DJ, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986; 327: 1077- 1081. PMID: 2871345 717. Tanaka Y, Kikuchi T, Nagasaki K, et al. Lower birth weight and visceral fat accumulation are related to hyperinsulinemia and insulin resistance in obese Japanese children. Hypertens Res 2005; 28: 529- 536. PMID: 16231759 718. Chen X, Wang Y. Tracking of blood pressure from childhood to adulthood: A systematic review and meta-regression analysis. Circulation 2008; 117: 3171-3180. PMID: 18559702 719. Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 2017; 140: e20171904. PMID: 28827377 720. Lurbe E, Agabiti-Rosei E, Cruickshank JK, et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens 2016; 34: 1887- 1920. PMID: 27467768 721. 菊池透,長崎啓祐,小川洋平,他.日本人小児の性別学年別血圧 基準値の検討(見附スタディから).小児高血圧研会誌 2011; 8: 21-25. 722. 菊池透,長崎啓祐,樋浦誠,他.小児肥満における血圧測定の有用性の検討.肥満研究 2005; 11: 69-73. 723. Litwin M, Niemirska A. Intima-media thickness measurements in children with cardiovascular risk factors. Pediatr Nephrol 2009; 24: 707-719. PMID: 18784945 724. McNiece KL, Gupta-Malhotra M, Samuels J, et al. National High Blood Pressure Education Program Working Group. Left ventricular hypertrophy in hypertensive adolescents: Analysis of risk by 2004 National High Blood Pressure Education Program Working Group staging criteria. Hypertension 2007; 50: 392-395. PMID: 17592068 725. Abe Y, Kikuchi T, Nagasaki K, et al. Lower birth weight associated with current overweight status is related with the metabolic syndrome in obese Japanese children. Hypertens Res 2007; 30: 627-634. PMID: 17785931 726. Zandi-Nejad K, Luyckx VA, Brenner BM. Adult hypertension and kidney disease: The role of fetal programming. Hypertension 2006; 47: 502-508. PMID: 16415374 727. Leyvraz M, Chatelan A, da Costa BR, et al. Sodium intake and blood pressure in children and adolescents: a systematic review and metaanalysis of experimental and observational studies. Int J Epidemiol 2018; 47: 1796-1810. PMID: 29955869 728. Okada T, Murata M, Yamauchi K, et al. New criteria of normal serum lipid levels in Japanese children: the nationwide study. Pediatr Int 2002; 44: 596-601. PMID: 12421254 729. Abe Y, Okada T, Sugiura R, et al. Reference ranges for the non-high-density lipoprotein cholesterol levels in Japanese children and adolescents. J Atheroscler Thromb 2015; 22: 669-675. PMID: 25739922 730. McGill HC Jr, McMahan CA, Zieske AW, et al. Association of Coronary Heart Disease Risk Factors with microscopic qualities of coronary atherosclerosis in youth. Circulation 2000; 102: 374-379. PMID: 10908207 731. 日本動脈硬化学会.動脈硬化性疾患予防ガイドライン2022年版.日本動脈硬化学会 2022: 157-165. 732. Groselj U, Kovac J, Sustar U, et al. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review. Atherosclerosis 2018; 277: 383-391. PMID: 30270075 733. Gidding SS, Wiegman A, Groselj U, et al. Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations. Eur J Prev Cardiol 2022; 29: 2301-2311. PMID: 36059237 734. 宮崎あゆみ,小栗絢子,市村昇悦.Non-HDL コレステロール値からみた家族性高コレステロール血症児頻度の考察.日小循誌2019; 35: 112-118. 735. Matsunaga K, Mizobuchi A, Ying Fu H, et al. Universal Screening for Familial Hypercholesterolemia in Children in Kagawa, Japan. J Atheroscler Thromb 2022; 29: 839-849. PMID: 34176852 736. Lozano P, Henrikson NB, Dunn J, et al. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2016; 316: 645-655. PMID: 27532919 737. Luirink IK, Wiegman A, Kusters DM, et al. 20-year follow-up of statins in children with familial hypercholesterolemia. N Engl J Med 2019; 381: 1547-1556. PMID: 31618540 738. Rodenburg J, Vissers MN, Wiegman A, et al. Statin treatment in children with familial hypercholesterolemia: The younger, the better. Circulation 2007; 116: 664-668. PMID: 17664376 739. 大竹明,菅野崇,栗原雄司,他.小児家族性高コレステロール血症に対するピタバスタチンの安全性及び有効性.日児誌 2020; 124: 1499-1508. 740. Després JP, Lemieux I, Bergeron J, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008; 28: 1039-1049. PMID: 18356555 741. Yoshinaga M, Sameshima K, Tanaka Y, et al. Adipokines and the prediction of the accumulation of cardiovascular risk factors or the presence of metabolic syndrome in elementary school children. Circ J 2008; 72: 1874-1878. PMID: 18812676 742. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990; 322: 882-889. PMID: 2314422 743. Asayama K, Hayashibe H, Endo A, et al. Threshold values of visceral fat and waist girth in Japanese obese children. Pediatr Int 2005; 47: 498-504. PMID: 16190954 744. Hara M, Saitou E, Iwata F, et al. Waist-to-height ratio is the best pre- dictor of cardiovascular disease risk factors in Japanese schoolchil-